Compounds > lactic acid

lactic acid and rifampin

lactic acid has been researched along with rifampin in 78 studies

Research

Studies (78)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (6.41)18.2507
2000's28 (35.90)29.6817
2010's41 (52.56)24.3611
2020's4 (5.13)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Denkbaş, EB; Kaitian, X; Pişkin, E; Tuncel, A1
Curran, TM; Ma, Y; Marquis, RE1
Blom, H; Borch, E; Dainty, R; Hagtvedt, T; Nerbrink, E; Nesbakken, T; Nissen, H1
Bain, DF; Cox, PJ; Munday, DL1
Hickey, AJ; O'Hara, P1
Dutt, M; Khuller, GK4
Hickey, AJ; Hopfer, R; Kazantseva, M; McMurray, DN; Newcomer, CE; O'Hara, P; Suarez, S1
Donald, PR; Elshof, JW; Janse van Rensburg, A; Laubscher, JA; Schoeman, JF1
Hu, J; Jiang, X; Zhang, W; Zhu, C1
Ain, Q; Garg, SK; Khuller, GK; Sharma, S1
Hickey, AJ; Sethuraman, VV1
Khuller, GK; Sharma, S; Ul-Ain, Q1
Bian, X; Chen, X; Jing, X; Liang, Q; Xu, X; Yang, L; Zeng, J1
Khuller, GK; Pandey, R; Prasad, B; Sharma, A; Sharma, S; Zahoor, A1
Khuller, GK; Pandey, R; Sharma, S; Zahoor, A1
Khuller, GK; Pandey, R1
Ando, S; Inagawa, H; Ito, F; Kochi, C; Makino, K; Nakajima, T; Shikamura, M; Soma, G; Terada, H1
Kajimoto, M; Kojima, S; Makino, K; Nakajima, T; Tomoda, K; Watanabe, D1
Makino, K; Tomoda, K1
Hasegawa, T; Hinata, H; Hirota, K; Inagawa, H; Ito, F; Kochi, C; Makino, K; Soma, G; Terada, H1
Atyabi, F; Dinarvand, R; Esmaeili, F; Hosseini-Nasr, M; Rad-Malekshahi, M; Samadi, N1
Kawai, Y; Makino, K; Nakajima, T; Nishiwaki, M; Ohkoshi, T; Tomoda, K1
Antimisiaris, SG; Dracopoulos, V; Fadda, AM; Manca, ML; Mourtas, S1
Hirota, K; Inagawa, H; Kohchi, C; Makino, K; Soma, G; Terada, H; Tomoda, K1
Makino, K; Nakajima, T; Ohkoshi, T; Tomoda, K1
Fujimori, H; Honnami, H; Ito, F; Kanamura, K; Kawakami, H; Makino, K1
Antimisiaris, SG; Fadda, AM; Loy, G; Manca, ML; Zaru, M1
Kabasawa, T; Ohashi, K; Okada, H; Ozeki, T1
Durbin, D; Edwards, DA; Elbert, KJ; Garcia-Contreras, L; Hickey, AJ; Padilla, DJ; Peloquin, CA; Sung, JC; Verberkmoes, JL1
Doan, TV; Olivier, JC1
Hasegawa, T; Hirota, K; Inagawa, H; Kohchi, C; Makino, K; Nakajima, T; Soma, G; Terada, H1
Fujiwara, N; Haga, M; Makino, K; Miyazaki, M; Nakajima, T; Onoshita, T; Shimizu, Y; Terada, H; Yamaya, N; Yokoyama, M1
Balasubramanian, S; Malathi, S1
Couet, W; Doan, TV; Olivier, JC1
Guru, BR; Hali, M; McPharlin, CM; Panyam, J; Toti, US; Whittum-Hudson, JA; Wykes, SM1
Choonara, YE; du Toit, LC; Jarvis, DL; Khan, RA; Kumar, P; Murphy, CS; Ndesendo, VM; Pillay, V1
Hasegawa, T; Hirota, K; Makino, K; Nakajima, T; Terada, H1
Chen, X; Gu, Y; Lee, JH; Lee, WY; Monteiro, DA; Wang, H1
Feng, H; Hu, C; Zhu, C1
Burt, HM; Gilchrist, SE; Letchford, K; Needham, D; Rickard, DL1
Bardy, A; Brillault, J; Diab, R; Gontijo, AV; Olivier, JC1
McConville, JT; Son, YJ1
Booysen, LL; Brooks, E; du Plessis, LH; Gilliland, J; Gruppo, V; Hansen, R; Kalombo, L; Kotze, AF; Lenaerts, A; Lungenhofer, P; Semete-Makokotlela, B; Swai, HS1
Hirota, K; Kawamoto, T; Makino, K; Nakajima, T; Terada, H1
Cheung, KM; Kong, T; Shum, HC; To, MK; Wang, L; Wu, J; Yeung, KW1
Bach, H; Burt, HM; Fazli, L; Gilchrist, SE; Lange, D; Letchford, K1
Egge-Jacobsen, W; Fenaroli, F; Griffiths, G; Kalluru, R; Khuller, GK; Koster, G; Maleki, A; Nyström, B; Paulsen Madsen, M; Roberg-Larsen, H; Roos, N; Singh, A; Ulanova, L; Westmoreland, D; Wilson, S1
Balasubramanian, S; Divakar, S; Gajendiran, M; Raaman, N1
Chawla, R; Jaiswal, S; Mishra, B1
Raj, V; Rajan, M1
Benjaminsen, J; Fenaroli, F; Griffiths, G; Hildahl, J; Kolstad, T; Meijer, AH; Nyström, B; Roos, N; Skjeldal, FM; Ulanova, L; van der Vaart, M; Westmoreland, D1
Cao, X; Wei, K; Wei, X; Xu, W; Zhong, S1
Dube, A; Fonteh, P; Hayeshi, R; Khumalo, V; Labuschagne, P; Lubuschagne, P; Madziva, MT; Meyer, D; Naicker, B; Ndamase, A; Swai, H; Tukulula, M1
Hu, Y; Jiang, D; Li, J; Qiao, B; Wang, J; Wu, J; Zuo, Y1
Cao, ZD; Jiang, DM; Li, YJ; Wang, X; Wang, ZL; Wu, J; Yan, L; Yi, YF1
Anes, E; Bogoeva, V; Fenaroli, F; Griffiths, G; Hildahl, J; Kalluru, R; Pires, D; Speth, M; Vibe, CB; Wilson, SR1
To, MK; Wu, J; Yeung, KW; Zhao, X1
Leng, FF; Li, HY; Liang, S; Lu, JF; Sun, HL; Zhu, Y1
Almouazen, E; Bourgeois, S; Fessi, H; Kodjikian, L; Lee, MY; Pelletier, J; Renaud, F1
Britton, WJ; Chan, HK; Leung, SS; Parumasivam, T; Quan, DH; Triccas, JA1
Jiang, JM; Lin, Z; Ma, XM; Qu, DB; Sang, CH; Zhang, JW1
Dai, W; Duan, C; Feng, X; Johnson, H; Li, J; Li, X; Liu, Z; Xiu, B; Yang, X; Zhang, H; Zhang, X1
Attalla, SM; Carter, WG; Christie, D; Elmorsy, E; Fikry, E; Kocon, A; Nwidu, LL; Turner, R; Warren, A1
Ding, Z; Lei, Q; Li, M; Liang, Y; Lu, T; Wu, J1
Jiang, D; Liu, Y1
Chen, Z; Huang, J; Li, L; Li, Y; Zhang, G1
Fenaroli, F; Griffiths, G; Misaghian, D; Nunes, C; Pinheiro, M; Reis, S; Ulanova, LS; Vibe, C; Wilson, S; Winther-Larsen, HC; Zhu, K1
Hierlemann, T; Krajewski, S; Müller, I; Reinbold, J; Schlensak, C; Uhde, AK; Urich, L; Vogel, U; Weindl, T; Wendel, HP1
Wu, G; Wu, WG; Zheng, QX; Zhou, JB1
Bairy, I; Gaonkar, SL; Guru, BR; Hakkimane, SS; Shenoy, VP1
Da Costa, D; Exbrayat-Héritier, C; Megy, S; Primard, C; Rambaud, B; Terreux, R; Verrier, B1
Allison, A; Fouladkhah, AC1
Castañeda-Fernandez, C; Chávez-Santos, RM; Espitia-Pinzón, C; Kozina, A; Martínez, R; Silva-Miranda, M1
Bhandari, RK; Kaur, G; Khuller, GK; Malhotra, S; Mittal, BR; Pandey, AK; Pandey, S; Rather, I; Shafiq, N; Sharma, N; Shukla, J1

Trials

1 trial(s) available for lactic acid and rifampin

ArticleYear
The effect of adjuvant steroid treatment on serial cerebrospinal fluid changes in tuberculous meningitis.
    Annals of tropical paediatrics, 2001, Volume: 21, Issue:4

    Topics: Adenylate Kinase; Antitubercular Agents; Cerebrospinal Fluid Proteins; Child; Child, Preschool; Drug Interactions; Drug Therapy, Combination; Female; Globulins; Glucocorticoids; Glucose; Humans; Infant; Lactic Acid; Lymphocyte Count; Male; Neutrophils; Prednisone; Rifampin; Statistics, Nonparametric; Tuberculosis, Meningeal

2001

Other Studies

77 other study(ies) available for lactic acid and rifampin

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Rifampicin-carrying poly(D,L-lactide) microspheres: loading and release.
    Journal of biomaterials science. Polymer edition, 1995, Volume: 6, Issue:9

    Topics: Biocompatible Materials; Biodegradation, Environmental; Delayed-Action Preparations; Drug Carriers; Excipients; Hydrogen-Ion Concentration; Lactates; Lactic Acid; Microspheres; Polyesters; Polymers; Rifampin; Solvents; Stereoisomerism; Temperature

1995
Rapid procedure for acid adaptation of oral lactic-acid bacteria and further characterization of the response.
    Canadian journal of microbiology, 1997, Volume: 43, Issue:2

    Topics: Acetic Acid; Anti-Bacterial Agents; Antibiotics, Antitubercular; Biological Transport; Biomass; Chloramphenicol; Culture Media; Fluorides; Glucose; Glycolysis; Hydrogen-Ion Concentration; Lactic Acid; Lacticaseibacillus casei; Protein Biosynthesis; Proteins; Proton-Motive Force; Rifampin; Streptococcus; Streptococcus mutans; Transcription, Genetic

1997
Addition of 2.5% lactate and 0.25% acetate controls growth of Listeria monocytogenes in vacuum-packed, sensory-acceptable servelat sausage and cooked ham stored at 4 degrees C.
    International journal of food microbiology, 1997, Aug-19, Volume: 38, Issue:1

    Topics: Acetic Acid; Animals; Antibiotics, Antitubercular; Cattle; Cold Temperature; Colony Count, Microbial; Consumer Behavior; Data Collection; Food Packaging; Food Preservatives; Hydrogen-Ion Concentration; Lactic Acid; Listeria monocytogenes; Meat Products; Mutation; Parabens; Rifampin; Swine

1997
Evaluation of biodegradable rifampicin-bearing microsphere formulations using a stability-indicating high-performance liquid chromatographic assay.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 1998, Volume: 7, Issue:1

    Topics: Antibiotics, Antitubercular; Antioxidants; Ascorbic Acid; Biocompatible Materials; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Stability; Hydrogen-Ion Concentration; Kinetics; Lactic Acid; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Reproducibility of Results; Rifampin

1998
Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: manufacture and characterization.
    Pharmaceutical research, 2000, Volume: 17, Issue:8

    Topics: Antibiotics, Antitubercular; Buffers; Desiccation; Drug Carriers; Lactic Acid; Microscopy, Electron, Scanning; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rifampin; Solvents; Surface Properties

2000
Therapeutic efficacy of Poly(DL-lactide-Co-Glycolide)-encapsulated antitubercular drugs against Mycobacterium tuberculosis infection induced in mice.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:1

    Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Biocompatible Materials; Drug Combinations; Drug Compounding; Isoniazid; Lactic Acid; Mice; Mycobacterium tuberculosis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rifampin; Tissue Distribution; Tuberculosis

2001
Chemotherapy of Mycobacterium tuberculosis infections in mice with a combination of isoniazid and rifampicin entrapped in Poly (DL-lactide-co-glycolide) microparticles.
    The Journal of antimicrobial chemotherapy, 2001, Volume: 47, Issue:6

    Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Capsules; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Drug Therapy, Combination; Female; Isoniazid; Lactic Acid; Male; Mice; Mycobacterium tuberculosis; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rifampin; Treatment Outcome; Tuberculosis

2001
Liposomes and PLG microparticles as sustained release antitubercular drug carriers--an in vitro-in vivo study.
    International journal of antimicrobial agents, 2001, Volume: 18, Issue:3

    Topics: Alkaline Phosphatase; Animals; Antibiotics, Antitubercular; Antitubercular Agents; Aspartate Aminotransferases; Bilirubin; Delayed-Action Preparations; Drug Carriers; Female; Isoniazid; Lactic Acid; Liposomes; Liver; Male; Mice; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rifampin; Tissue Distribution

2001
Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: screening in an infectious disease model.
    Pharmaceutical research, 2001, Volume: 18, Issue:9

    Topics: Administration, Inhalation; Aerosols; Animals; Antibiotics, Antitubercular; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Evaluation, Preclinical; Guinea Pigs; Indicators and Reagents; Lactic Acid; Lung; Macrophages; Male; Microbial Sensitivity Tests; Microspheres; Mycobacterium tuberculosis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rifampin; Tuberculosis

2001
[Study on the rifampicin polylactic acid microspheres for lung targeting].
    Yao xue xue bao = Acta pharmaceutica Sinica, 1998, Volume: 33, Issue:1

    Topics: Animals; Antibiotics, Antitubercular; Delayed-Action Preparations; Lactic Acid; Lung; Male; Microspheres; Polyesters; Polymers; Rabbits; Rifampin; Tissue Distribution

1998
Role of poly [DL-lactide-co-glycolide] in development of a sustained oral delivery system for antitubercular drug(s).
    International journal of pharmaceutics, 2002, Jun-04, Volume: 239, Issue:1-2

    Topics: Administration, Oral; Animals; Antibiotics, Antitubercular; Antitubercular Agents; Area Under Curve; Biocompatible Materials; Capsules; Delayed-Action Preparations; Drug Compounding; Female; Half-Life; Isoniazid; Lactic Acid; Male; Mice; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Pyrazinamide; Rifampin; Solubility

2002
Poly (DL-lactide-co-glycolide) microparticles as carriers for antimycobacterial drug rifampicin.
    Indian journal of experimental biology, 2000, Volume: 38, Issue:9

    Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Antibiotics, Antitubercular; Bilirubin; Biocompatible Materials; Drug Carriers; Drug Delivery Systems; Female; In Vitro Techniques; Lactic Acid; Liver; Male; Mice; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rifampin

2000
Powder properties and their influence on dry powder inhaler delivery of an antitubercular drug.
    AAPS PharmSciTech, 2002, Volume: 3, Issue:4

    Topics: Administration, Inhalation; Aerosols; Antitubercular Agents; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Drug Delivery Systems; Lactic Acid; Lactose; Microscopy, Electron, Scanning; Models, Chemical; Particle Size; Pharmaceutical Preparations; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Powders; Rifampin; Surface Properties; Thermogravimetry; Time Factors

2002
Chemotherapeutic potential of orally administered poly(lactide-co-glycolide) microparticles containing isoniazid, rifampin, and pyrazinamide against experimental tuberculosis.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:9

    Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Area Under Curve; Biocompatible Materials; Biological Availability; Capsules; Drug Combinations; Drug Compounding; Isoniazid; Lactic Acid; Mice; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Pyrazinamide; Rifampin; Tissue Distribution; Tuberculosis, Pulmonary

2003
Biodegradable electrospun fibers for drug delivery.
    Journal of controlled release : official journal of the Controlled Release Society, 2003, Oct-30, Volume: 92, Issue:3

    Topics: Biodegradation, Environmental; Delayed-Action Preparations; Doxorubicin; Drug Carriers; Drug Delivery Systems; Endopeptidase K; Hydrophobic and Hydrophilic Interactions; Lactic Acid; Microscopy, Electron, Scanning; Nanotechnology; Paclitaxel; Polyesters; Polymers; Rifampin; Sodium Dodecyl Sulfate; Spectrophotometry, Ultraviolet; Static Electricity; Surface-Active Agents

2003
Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis.
    The Journal of antimicrobial chemotherapy, 2003, Volume: 52, Issue:6

    Topics: Administration, Inhalation; Aerosols; Animals; Antibiotics, Antitubercular; Antitubercular Agents; Area Under Curve; Biological Availability; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemistry, Physical; Colony Count, Microbial; Drug Carriers; Drug Combinations; Drug Compounding; Female; Guinea Pigs; Half-Life; Injections, Intravenous; Isoniazid; Lactic Acid; Lung; Male; Microspheres; Mycobacterium tuberculosis; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Pyrazinamide; Rifampin; Tuberculosis

2003
Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis.
    Tuberculosis (Edinburgh, Scotland), 2003, Volume: 83, Issue:6

    Topics: Administration, Oral; Animals; Antitubercular Agents; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Female; Glycolates; Isoniazid; Lactic Acid; Liver; Lung; Male; Mice; Mycobacterium tuberculosis; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrazinamide; Rifampin; Spleen; Tuberculosis

2003
Subcutaneous nanoparticle-based antitubercular chemotherapy in an experimental model.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 54, Issue:1

    Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Biological Availability; Drug Combinations; Drug Compounding; Injections, Subcutaneous; Isoniazid; Lactic Acid; Lung; Mice; Microspheres; Mycobacterium tuberculosis; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Pyrazinamide; Rifampin; Spleen; Tissue Distribution; Tuberculosis

2004
Efficient intracellular delivery of rifampicin to alveolar macrophages using rifampicin-loaded PLGA microspheres: effects of molecular weight and composition of PLGA on release of rifampicin.
    Colloids and surfaces. B, Biointerfaces, 2004, Jul-01, Volume: 36, Issue:1

    Topics: Animals; Antibiotics, Antitubercular; Cell Line; Culture Media; Delayed-Action Preparations; Drug Delivery Systems; Kinetics; Lactic Acid; Macrophages, Alveolar; Microspheres; Molecular Weight; Particle Size; Phagocytosis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rifampin

2004
Effects of pulmonary surfactant system on rifampicin release from rifampicin-loaded PLGA microspheres.
    Colloids and surfaces. B, Biointerfaces, 2005, Sep-25, Volume: 45, Issue:1

    Topics: Lactic Acid; Macrophages, Alveolar; Microscopy, Electron, Scanning; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Pulmonary Surfactants; Rifampin

2005
Effects of lung surfactants on rifampicin release rate from monodisperse rifampicin-loaded PLGA microspheres.
    Colloids and surfaces. B, Biointerfaces, 2007, Mar-15, Volume: 55, Issue:1

    Topics: Humans; Lactic Acid; Microspheres; Molecular Weight; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Pulmonary Surfactants; Rifampin; Surface Properties; Time Factors

2007
Optimum conditions for efficient phagocytosis of rifampicin-loaded PLGA microspheres by alveolar macrophages.
    Journal of controlled release : official journal of the Controlled Release Society, 2007, May-14, Volume: 119, Issue:1

    Topics: Animals; Cell Survival; Drug Carriers; Lactic Acid; Macrophages, Alveolar; Microspheres; Phagocytosis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rifampin

2007
Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles.
    Nanomedicine : nanotechnology, biology, and medicine, 2007, Volume: 3, Issue:2

    Topics: Anti-Bacterial Agents; Bacteria; Cell Survival; Coated Materials, Biocompatible; Drug Carriers; Lactic Acid; Materials Testing; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rifampin

2007
Preparation and properties of inhalable nanocomposite particles: effects of the temperature at a spray-dryer inlet upon the properties of particles.
    Colloids and surfaces. B, Biointerfaces, 2008, Feb-15, Volume: 61, Issue:2

    Topics: Administration, Inhalation; Calorimetry, Differential Scanning; Carbohydrates; Lactic Acid; Nanocomposites; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rifampin; Temperature; Water

2008
PLGA, chitosan or chitosan-coated PLGA microparticles for alveolar delivery? A comparative study of particle stability during nebulization.
    Colloids and surfaces. B, Biointerfaces, 2008, Apr-01, Volume: 62, Issue:2

    Topics: Adhesiveness; Administration, Inhalation; Antibiotics, Antitubercular; Cell Line; Chemical Phenomena; Chemistry, Physical; Chitosan; Diffusion; Drug Compounding; Drug Delivery Systems; Drug Stability; Electrochemistry; Emulsions; Humans; Lactic Acid; Microscopy, Electron, Scanning; Microspheres; Molecular Weight; Mucins; Mucous Membrane; Nebulizers and Vaporizers; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Pulmonary Alveoli; Rifampin; Solvents; Tetrazolium Salts; Thiazoles

2008
Stimulation of phagocytic activity of alveolar macrophages toward artificial microspheres by infection with mycobacteria.
    Pharmaceutical research, 2008, Volume: 25, Issue:6

    Topics: Animals; Cell Survival; Cells, Cultured; Escherichia coli; Lactic Acid; Macrophages, Alveolar; Microspheres; Mycobacterium; Mycobacterium bovis; Nitric Oxide; Phagocytosis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rifampin; Tumor Necrosis Factor-alpha

2008
Preparation and properties of inhalable nanocomposite particles: effects of the size, weight ratio of the primary nanoparticles in nanocomposite particles and temperature at a spray-dryer inlet upon properties of nanocomposite particles.
    Colloids and surfaces. B, Biointerfaces, 2008, Jun-15, Volume: 64, Issue:1

    Topics: Administration, Inhalation; Aerosols; Antibiotics, Antitubercular; Lactic Acid; Nanocomposites; Nanoparticles; Nebulizers and Vaporizers; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin; Temperature

2008
Effect of polyethylene glycol on preparation of rifampicin-loaded PLGA microspheres with membrane emulsification technique.
    Colloids and surfaces. B, Biointerfaces, 2008, Oct-01, Volume: 66, Issue:1

    Topics: Antibiotics, Antitubercular; Drug Carriers; Drug Delivery Systems; Emulsions; Lactic Acid; Membranes, Artificial; Microspheres; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polyvinyl Alcohol; Rifampin

2008
Release of rifampicin from chitosan, PLGA and chitosan-coated PLGA microparticles.
    Colloids and surfaces. B, Biointerfaces, 2008, Dec-01, Volume: 67, Issue:2

    Topics: Chitosan; Drug Carriers; Drug Delivery Systems; Drug Stability; Kinetics; Lactic Acid; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin

2008
One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
    Journal of controlled release : official journal of the Controlled Release Society, 2009, Apr-02, Volume: 135, Issue:1

    Topics: Administration, Inhalation; Administration, Intranasal; Aerosols; Animals; Antibiotics, Antitubercular; Cell Line; Drug Carriers; Drug Compounding; Lactic Acid; Lung; Macrophages, Alveolar; Male; Mannitol; Microscopy, Electron, Scanning; Microspheres; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Rifampin; Surface Properties

2009
Formulation and pharmacokinetics of self-assembled rifampicin nanoparticle systems for pulmonary delivery.
    Pharmaceutical research, 2009, Volume: 26, Issue:8

    Topics: Animals; Antitubercular Agents; Chemistry, Pharmaceutical; Guinea Pigs; Lactic Acid; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin

2009
Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization.
    International journal of pharmaceutics, 2009, Dec-01, Volume: 382, Issue:1-2

    Topics: Acetates; Administration, Inhalation; Aerosols; Animals; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Emulsions; Kinetics; Lactic Acid; Membranes, Artificial; Microspheres; Oils; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pressure; Rats; Rifampin; Solubility; Solvents; Technology, Pharmaceutical; Water

2009
Delivery of rifampicin-PLGA microspheres into alveolar macrophages is promising for treatment of tuberculosis.
    Journal of controlled release : official journal of the Controlled Release Society, 2010, Mar-19, Volume: 142, Issue:3

    Topics: Animals; Antibiotics, Antitubercular; Cell Line; Cell Survival; Drug Carriers; Interleukin-10; Lactic Acid; Macrophages, Alveolar; Microspheres; Mycobacterium bovis; Nitric Oxide; Phagocytosis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rifampin; Tissue Distribution; Tuberculosis; Tumor Necrosis Factor-alpha

2010
The behavior of PLGA microspheres containing rifampicin in alveolar macrophages.
    Colloids and surfaces. B, Biointerfaces, 2010, Mar-01, Volume: 76, Issue:1

    Topics: Animals; Cell Line; Hydrogen-Ion Concentration; Lactic Acid; Macrophages, Alveolar; Microscopy, Electron, Scanning; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rifampin; Time Factors

2010
Synthesis of biodegradable polymeric nanoparticles and their controlled drug delivery for tuberculosis.
    Journal of biomedical nanotechnology, 2011, Volume: 7, Issue:1

    Topics: Absorbable Implants; Antitubercular Agents; Delayed-Action Preparations; Diffusion; Drug Compounding; Humans; Lactic Acid; Nanocapsules; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin; Tuberculosis

2011
Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery.
    International journal of pharmaceutics, 2011, Jul-29, Volume: 414, Issue:1-2

    Topics: Acetates; Aerosols; Antibiotics, Antitubercular; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Delivery Systems; Excipients; Lactic Acid; Lung; Membranes, Artificial; Microspheres; Models, Theoretical; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rifampin; Solvents

2011
Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticles.
    Biomaterials, 2011, Volume: 32, Issue:27

    Topics: Anti-Bacterial Agents; Azithromycin; Cell Line; Chemistry, Pharmaceutical; Chlamydia Infections; Chlamydia trachomatis; Coumarins; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Synergism; Humans; Intracellular Space; Lactic Acid; Microbial Sensitivity Tests; Microbial Viability; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin; Time Factors

2011
Polymeric emulsion and crosslink-mediated synthesis of super-stable nanoparticles as sustained-release anti-tuberculosis drug carriers.
    Colloids and surfaces. B, Biointerfaces, 2011, Oct-15, Volume: 87, Issue:2

    Topics: Alginates; Calcium Chloride; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Emulsions; Glucuronic Acid; Hexoses; Hexuronic Acids; Humans; Hydrogels; Isoniazid; Lactic Acid; Microscopy, Electron, Scanning; Models, Molecular; Nanoparticles; Organic Chemistry Phenomena; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin; Spectrum Analysis; Thermodynamics; Tuberculosis

2011
Phagostimulatory effect of uptake of PLGA microspheres loaded with rifampicin on alveolar macrophages.
    Colloids and surfaces. B, Biointerfaces, 2011, Oct-15, Volume: 87, Issue:2

    Topics: Animals; Antitubercular Agents; Cell Line; Drug Delivery Systems; Fluorescent Dyes; Lactic Acid; Macrophages, Alveolar; Microspheres; Particle Size; Phagocytosis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polystyrenes; Rats; Rifampin; Tuberculosis

2011
Inkjet printed antibiotic- and calcium-eluting bioresorbable nanocomposite micropatterns for orthopedic implants.
    Acta biomaterialia, 2012, Volume: 8, Issue:1

    Topics: Alloys; Antibiotics, Antitubercular; Biofilms; Calcium; Calcium Phosphates; Cell Differentiation; Cell Proliferation; Cells, Cultured; Humans; Lactic Acid; Materials Testing; Microscopy, Electron, Scanning; Nanocomposites; Orthopedic Fixation Devices; Osteoblasts; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Printing; Rifampin; Staphylococcus epidermidis; Surface Properties; Titanium

2012
Preparation and characterization of rifampicin-PLGA microspheres/sodium alginate in situ gel combination delivery system.
    Colloids and surfaces. B, Biointerfaces, 2012, Jun-15, Volume: 95

    Topics: Alginates; Animals; Calorimetry, Differential Scanning; Drug Delivery Systems; Gels; Glucuronic Acid; Hexuronic Acids; Lactic Acid; Male; Mice; Mice, Nude; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Rifampin; Surface Properties

2012
Phase separation behavior of fusidic acid and rifampicin in PLGA microspheres.
    Molecular pharmaceutics, 2012, May-07, Volume: 9, Issue:5

    Topics: Calorimetry, Differential Scanning; Drug Compounding; Fusidic Acid; Lactic Acid; Microscopy, Confocal; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin; Spectrum Analysis, Raman

2012
Formulation and in vitro characterization of inhalable polyvinyl alcohol-free rifampicin-loaded PLGA microspheres prepared with sucrose palmitate as stabilizer: efficiency for ex vivo alveolar macrophage targeting.
    International journal of pharmaceutics, 2012, Oct-15, Volume: 436, Issue:1-2

    Topics: Animals; Antibiotics, Antitubercular; Cell Survival; Cells, Cultured; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Lactic Acid; Macrophages, Alveolar; Male; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polyvinyl Alcohol; Rats; Rats, Sprague-Dawley; Rifampin; Sucrose

2012
Preparation of sustained release rifampicin microparticles for inhalation.
    The Journal of pharmacy and pharmacology, 2012, Volume: 64, Issue:9

    Topics: Administration, Inhalation; Aerosols; Antibiotics, Antitubercular; Delayed-Action Preparations; Drug Compounding; Drug Delivery Systems; Drug Stability; Drug Storage; Humans; Kinetics; Lactic Acid; Microscopy, Electron, Scanning; Molecular Conformation; Particle Size; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Powders; Rifampin; Solubility; Surface Properties; Water

2012
In vivo/in vitro pharmacokinetic and pharmacodynamic study of spray-dried poly-(dl-lactic-co-glycolic) acid nanoparticles encapsulating rifampicin and isoniazid.
    International journal of pharmaceutics, 2013, Feb-28, Volume: 444, Issue:1-2

    Topics: Animals; Antibiotics, Antitubercular; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Female; Isoniazid; Lactic Acid; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin

2013
Distribution and deposition of respirable PLGA microspheres in lung alveoli.
    Colloids and surfaces. B, Biointerfaces, 2013, May-01, Volume: 105

    Topics: Administration, Inhalation; Animals; Antibiotics, Antitubercular; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Coumarins; Fluorescence; Immunoenzyme Techniques; Lactic Acid; Lung; Macrophages, Alveolar; Male; Microspheres; Phagocytosis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Rifampin; Thiazoles; Tissue Distribution; Trachea

2013
Fabrication and characterization of monodisperse PLGA-alginate core-shell microspheres with monodisperse size and homogeneous shells for controlled drug release.
    Acta biomaterialia, 2013, Volume: 9, Issue:7

    Topics: Alginates; Animals; Capsules; Cell Line; Cell Survival; Crystallization; Delayed-Action Preparations; Diffusion; Gels; Glucuronic Acid; Hexuronic Acids; Lactic Acid; Materials Testing; Mice; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin; Surface Properties

2013
Fusidic acid and rifampicin co-loaded PLGA nanofibers for the prevention of orthopedic implant associated infections.
    Journal of controlled release : official journal of the Controlled Release Society, 2013, Aug-28, Volume: 170, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Arthroplasty, Replacement; Bacterial Infections; Drug Delivery Systems; Female; Fusidic Acid; Lactic Acid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nanofibers; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prostheses and Implants; Prosthesis-Related Infections; Rats; Rats, Sprague-Dawley; Rifampin; Staphylococcus epidermidis

2013
Poly(lactide-co-glycolide)-rifampicin nanoparticles efficiently clear Mycobacterium bovis BCG infection in macrophages and remain membrane-bound in phago-lysosomes.
    Journal of cell science, 2013, Jul-15, Volume: 126, Issue:Pt 14

    Topics: Animals; Antibiotics, Antitubercular; Cell Line; Cell Membrane; Colony Count, Microbial; Drug Carriers; Female; Lactic Acid; Macrophages; Male; Mice; Mycobacterium bovis; Nanoparticles; Phagosomes; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin

2013
In vitro drug release behavior, mechanism and antimicrobial activity of rifampicin loaded low molecular weight PLGA-PEG-PLGA triblock copolymeric nanospheres.
    Current drug delivery, 2013, Volume: 10, Issue:6

    Topics: Anti-Bacterial Agents; Chromatography, Gel; Delayed-Action Preparations; Diffusion; Drug Carriers; Lactic Acid; Magnetic Resonance Spectroscopy; Microspheres; Molecular Weight; Nanospheres; Polyethylene Glycols; Polyglactin 910; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rifampin; Spectroscopy, Fourier Transform Infrared; Tetracycline; Viscosity; X-Ray Diffraction

2013
Development and optimization of polymeric nanoparticles of antitubercular drugs using central composite factorial design.
    Expert opinion on drug delivery, 2014, Volume: 11, Issue:1

    Topics: Animals; Antitubercular Agents; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Isoniazid; Lactic Acid; Macrophages, Peritoneal; Male; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Rifampin

2014
Formation and characterization of chitosan-polylacticacid-polyethylene glycol-gelatin nanoparticles: a novel biosystem for controlled drug delivery.
    Carbohydrate polymers, 2013, Oct-15, Volume: 98, Issue:1

    Topics: Chitosan; Delayed-Action Preparations; Drug Carriers; Gelatin; Lactic Acid; Mycobacterium smegmatis; Nanoparticles; Particle Size; Polyesters; Polyethylene Glycols; Polymers; Rifampin; Solvents; Volatilization

2013
Nanoparticles as drug delivery system against tuberculosis in zebrafish embryos: direct visualization and treatment.
    ACS nano, 2014, Jul-22, Volume: 8, Issue:7

    Topics: Animals; Anti-Bacterial Agents; Biological Transport; Coumarins; Drug Carriers; Embryo, Nonmammalian; Granuloma; Lactic Acid; Macrophages; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Nanoparticles; Optical Imaging; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rhodamines; Rifampin; Thiazoles; Tuberculosis; Zebrafish

2014
A mesoporous silicon/poly-(DL-lactic-co-glycolic) acid microsphere for long time anti-tuberculosis drug delivery.
    International journal of pharmaceutics, 2014, Dec-10, Volume: 476, Issue:1-2

    Topics: Antitubercular Agents; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Liberation; Hydrophobic and Hydrophilic Interactions; Isoniazid; Lactic Acid; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin; Silicon Dioxide; Time Factors

2014
Curdlan-Conjugated PLGA Nanoparticles Possess Macrophage Stimulant Activity and Drug Delivery Capabilities.
    Pharmaceutical research, 2015, Volume: 32, Issue:8

    Topics: Antitubercular Agents; beta-Glucans; Biological Transport, Active; Caco-2 Cells; Carbohydrate Sequence; Cell Membrane Permeability; Cell Survival; Chemistry, Pharmaceutical; Drug Delivery Systems; Excipients; Humans; Intestinal Absorption; Lactic Acid; Macrophages; Molecular Sequence Data; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin; Stimulation, Chemical

2015
Development and in vitro characterization of drug delivery system of rifapentine for osteoarticular tuberculosis.
    Drug design, development and therapy, 2015, Volume: 9

    Topics: Drug Delivery Systems; Lactic Acid; Microbial Sensitivity Tests; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin; Staphylococcus aureus; Surface Properties; Tuberculosis, Osteoarticular

2015
Treatment of Staphylococcus aureus-induced chronic osteomyelitis with bone-like hydroxyapatite/poly amino acid loaded with rifapentine microspheres.
    Drug design, development and therapy, 2015, Volume: 9

    Topics: Amino Acids; Animals; Anti-Bacterial Agents; Chronic Disease; Delayed-Action Preparations; Drug Carriers; Durapatite; Lactic Acid; Microspheres; Osteomyelitis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Rifampin; Staphylococcal Infections; Staphylococcus aureus

2015
Thioridazine in PLGA nanoparticles reduces toxicity and improves rifampicin therapy against mycobacterial infection in zebrafish.
    Nanotoxicology, 2016, Volume: 10, Issue:6

    Topics: Animals; Antitubercular Agents; Cell Survival; Cells, Cultured; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Lactic Acid; Macrophages; Male; Mice, Inbred C57BL; Mycobacterium tuberculosis; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin; Thioridazine; Tuberculosis; Zebrafish

2016
Interfacial Fast Release Layer in Monodisperse Poly (lactic-co-glycolic acid) Microspheres Accelerates the Drug Release.
    Current drug delivery, 2016, Volume: 13, Issue:5

    Topics: Delayed-Action Preparations; Drug Carriers; Drug Compounding; Kinetics; Lactic Acid; Microfluidic Analytical Techniques; Microscopy, Electron, Scanning; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Rifampin; Solubility; Surface Properties; Technology, Pharmaceutical

2016
Highly efficient production of hyaluronic acid by Streptococcus zooepidemicus R42 derived from heterologous expression of bacterial haemoglobin and mutant selection.
    Letters in applied microbiology, 2016, Volume: 62, Issue:4

    Topics: Acetic Acid; Biomass; Fermentation; Glutamic Acid; Hemoglobins; Hyaluronic Acid; Lactic Acid; Maltose; Methylnitronitrosoguanidine; Rifampin; Streptococcus equi; Sucrose

2016
Microencapsulation of rifampicin for the prevention of endophthalmitis: In vitro release studies and antibacterial assessment.
    International journal of pharmaceutics, 2016, May-30, Volume: 505, Issue:1-2

    Topics: Anti-Bacterial Agents; Bacterial Adhesion; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Liberation; Endophthalmitis; Lactic Acid; Microbial Sensitivity Tests; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Time Factors

2016
Rifapentine-loaded PLGA microparticles for tuberculosis inhaled therapy: Preparation and in vitro aerosol characterization.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2016, Jun-10, Volume: 88

    Topics: Administration, Inhalation; Aerosols; Antitubercular Agents; Cell Line; Cell Survival; Chemistry, Pharmaceutical; Drug Delivery Systems; Humans; Lactic Acid; Lung; Microscopy, Electron, Scanning; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin

2016
[Fabrication of a new composite scaffold material for delivering rifampicin and its sustained drug release in rats].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2016, Volume: 36, Issue:3

    Topics: Animals; Biocompatible Materials; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Lactic Acid; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rifampin

2016
A novel and simple preparative method for uniform-sized PLGA microspheres: Preliminary application in antitubercular drug delivery.
    Colloids and surfaces. B, Biointerfaces, 2016, Sep-01, Volume: 145

    Topics: Animals; Antitubercular Agents; Centrifugation; Drug Delivery Systems; Intracellular Space; Lactic Acid; Macrophages; Mice; Microspheres; Particle Size; Phagocytosis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; RAW 264.7 Cells; Rifampin

2016
Adverse effects of anti-tuberculosis drugs on HepG2 cell bioenergetics.
    Human & experimental toxicology, 2017, Volume: 36, Issue:6

    Topics: Adenosine Triphosphate; Antitubercular Agents; Drug Interactions; Electron Transport Complex I; Electron Transport Complex III; Energy Metabolism; Hep G2 Cells; Humans; Isoniazid; Lactic Acid; Membrane Potential, Mitochondrial; NAD; Pyrazinamide; Rifampin

2017
[An experimental study on a slow-release complex with rifampicin-polylactic-co-glycolic acid-calcium 
phosphate cement].
    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2016, Sep-28, Volume: 41, Issue:9

    Topics: Bone Cements; Calcium Phosphates; Compressive Strength; Delayed-Action Preparations; Dental Cements; Lactic Acid; Materials Testing; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Rifampin

2016
Effect of bone-like hydroxyapatite/poly amino acid loaded with rifapentine microspheres on bone and joint tuberculosis in vitro.
    Cell biology international, 2017, Volume: 41, Issue:4

    Topics: Cell Differentiation; Cell Line, Tumor; Drug Carriers; Durapatite; Humans; Lactic Acid; Microbial Sensitivity Tests; Microspheres; Mycobacterium tuberculosis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin; Tuberculosis, Osteoarticular; Wnt Signaling Pathway

2017
Rifapentine-linezolid-loaded PLGA microspheres for interventional therapy of cavitary pulmonary tuberculosis: preparation and in vitro characterization.
    Drug design, development and therapy, 2017, Volume: 11

    Topics: Animals; Bronchoscopy; Dogs; Female; Lactic Acid; Linezolid; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin; Surface Properties; Tuberculosis, Pulmonary

2017
Treatment of Francisella infections via PLGA- and lipid-based nanoparticle delivery of antibiotics in a zebrafish model.
    Diseases of aquatic organisms, 2017, 06-19, Volume: 125, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Fish Diseases; Francisella; Gram-Negative Bacterial Infections; Lactic Acid; Lipids; Nanoparticles; Oxolinic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin; Zebrafish

2017
Biodegradable rifampicin-releasing coating of surgical meshes for the prevention of bacterial infections.
    Drug design, development and therapy, 2017, Volume: 11

    Topics: Animals; Anti-Bacterial Agents; Coated Materials, Biocompatible; Delayed-Action Preparations; Drug Liberation; Female; Lactic Acid; Mice; Mice, Inbred C57BL; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polypropylenes; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Surgical Mesh; Surgical Wound Infection; Time Factors

2017
Fabrication of Isoniazid/Rifampicin/Poly L-lactic Acid Donut-shaped Implants via Three Dimensional Printing Technique.
    Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 2017, Dec-20, Volume: 39, Issue:6

    Topics: Delayed-Action Preparations; Isoniazid; Lactic Acid; Polyesters; Powders; Printing, Three-Dimensional; Prostheses and Implants; Rifampin

2017
Antimycobacterial susceptibility evaluation of rifampicin and isoniazid benz-hydrazone in biodegradable polymeric nanoparticles against
    International journal of nanomedicine, 2018, Volume: 13

    Topics: A549 Cells; Animals; Antitubercular Agents; Biocompatible Materials; Cell Death; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Drug Compounding; Drug Delivery Systems; Drug Liberation; Humans; Isoniazid; Lactic Acid; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Proton Magnetic Resonance Spectroscopy; RAW 264.7 Cells; Rifampin; Static Electricity; Surface Tension; Tuberculosis

2018
Surface charge modulation of rifampicin-loaded PLA nanoparticles to improve antibiotic delivery in Staphylococcus aureus biofilms.
    Journal of nanobiotechnology, 2021, Jan-07, Volume: 19, Issue:1

    Topics: Anti-Bacterial Agents; Biofilms; Drug Delivery Systems; Drug Liberation; Lactic Acid; Microbial Sensitivity Tests; Nanoparticles; Polyesters; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Surface Properties

2021
Sensitivity of wild-type and rifampicin-resistant O157 and non-O157 Shiga toxin-producing Escherichia coli to elevated hydrostatic pressure and lactic acid in ground meat and meat homogenate.
    PloS one, 2021, Volume: 16, Issue:2

    Topics: Drug Resistance, Bacterial; Hydrogen-Ion Concentration; Hydrostatic Pressure; Lactic Acid; Limit of Detection; Meat Products; Microbiota; Phenotype; Rifampin; Shiga-Toxigenic Escherichia coli; Temperature

2021
Optimization of rifampicin encapsulation in PLGA polymeric reservoirs.
    International journal of pharmaceutics, 2022, Jun-25, Volume: 622

    Topics: Emulsions; Lactic Acid; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin; Solvents

2022
Bio-evaluation of poly(lactic-co-glycolic) acid nanoparticles loaded with radiolabelled rifampicin.
    British journal of clinical pharmacology, 2023, Volume: 89, Issue:12

    Topics: Drug Carriers; Glycols; Humans; Lactic Acid; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin; Tissue Distribution

2023